In the last 3 months. On the site you’ll find the news from the last 3 months. The older ones only have the title and a link, in file by topicsIt’s a support website for people with multiple myeloma. It aims to keep things simple and clear. MielomaAI As you may find.
Collected from Portuguese newspapers, Google News (PT, EN, ES, FR) and associations and scientific societies. They are on the website 197 news: only from the last 3 months. The older ones are only shown with the title and link, in file by topicsAnd research and the MielomaAI You continue to find them. Always consult the original news article and speak with your doctor before drawing conclusions about your case. Last update: November 17, 2026, 3:21 PM.
Tuesday, November 17
Photon-Counting CT Improves Image Quality and Cuts Radiation Dose in MyelomaBioengineer.org · 14:05 OutrasA retrospective comparative study shows photon-counting computed tomography delivers higher image quality and reduced radiation doses in multiple myeloma patients.
- Pfizer Multiple Myeloma Education GrantOncodaily · 10:41 Outras
Cobertura jornalística abrangente e atualizada, reunida a partir de fontes em todo o mundo pelo Google News.
Hi everyone, Recently my dad got diagnosed with myeloma. My dad and the rest of my family live in New Zealand and I live in Canada. I’ll be completing the Ironman in Ottawa 2027 to raise awareness for treatment for Myeloma. I’ll be documenting the trainingFacebook (Internacional) · 03:22 Doentes e associaçõesInternacional
Monday, 16/11
Viviana was diagnosed with myeloma in 2024 and was told it could be treated but that there wasn't a cure. She'd previously been living with monoclonal gammopathy of undetermined significance (MGUS), a blood condition that can develop into blood cancer.Facebook (Internacional) · 19:00 Doentes e associaçõesInternacional
Ben Derman։ Top 10 Myeloma Abstracts to Be Presented at ASH 2026Oncodaily · 18:05 InvestigaçãoBen Derman։ Top 10 Myeloma Abstracts to Be Presented at ASH 2026 / ASCO, ASH 2026, Ben Derman, cancer, CAR-T, DARA, Daratumumab, Lenalidomide, Mount Sinai,
MRD Ready to Guide Multiple Myeloma Treatment Decisions?MedPage Today · 17:32 Tratamentos'MRD is becoming a very valuable tool, but it's not an exclusive tool,' says expert
Next-Generation Multiple Myeloma Therapies Market to ReachopenPR.com · 16:44 TratamentosNovember 16 2026 Multiple myeloma treatment is expanding across antibody combinations CAR T cell therapies and newer immune modifying drugs Recent U S approvals have brought some options into earlier treatment lines while new subcutaneous formulations are changing how antibody ...
https://rarecancernews.com/news/under-the-skin-myeloma-treatment-linked-better-survival-study/ Interesting article.Facebook (Internacional) · 16:42 Doentes e associaçõesInternacional
Tempest acquires rights to experimental myeloma treatmentRare Cancer News · 16:28 TratamentosTempest Therapeutics has exercised an option to obtain rights to develop and commercialize an experimental treatment for myeloma.
Sanofi and the Alliance Pharmaceutical PanCanadian sign a letter of intent for Sarclisa® (isatuximab), a further step towards public access for newly diagnosed patients with multiple myeloma who are not eligible for a transplant.PR Newswire Canada (Canada) · 14:15 TreatmentsCan you provide the French text you want me to translate?FR/CNW/ -- Sanofi announced today the happy conclusion of negotiations with the Canadian Alliance Pharmaceutical (CPP), marked by the signing of a...
Sanofi and the pan-Canadian Pharmaceutical Alliance sign Letter of Intent for Sarclisa®(isatuximab), a step toward public access for newly diagnosed, transplant-ineligible multiple myeloma patientsPR Newswire Canada (Canadá) · 14:15 Doentes e associaçõesCanadá
Lola Manterola, from CRIS Against Cancer, Receives Research Award at the Woman 2026 Awards: the woman who turned her experience with cancer into an opportunity for thousands of patients.Woman Madame Figaro · 12:41 Patients and associationsESMultiple myeloma survivor, has turned his experience with the disease into a firm commitment to drive oncology research and give hope to thousands of patients. For them, it is our 2026 Woman Awards Research Prize.
Teclistamab Plus Daratumumab in Multiple Myeloma: FDA Adverse Event Reporting System AnalysisOncodaily · 11:23 TratamentosTeclistamab Plus Daratumumab in Multiple Myeloma: FDA Adverse Event Reporting System Analysis / BCMA, BCMA × CD3 bispecific antibody, Daratumumab, FDA
Pablo Sánchez, singer from La Raíz, returns after cancer with a novel: “Now I need to write to remain.Levante-EMV · 10:10 Patients and associationsESThe musician from Gandia, in complete remission from his multiple myeloma which had taken him away from the stage, publishes on November 24th ‘At the Shore of Krakatoa’, a fictional story born during his treatment.
Can You Recognize the Oil Droplet Appearance? Multiple well-defined, punched-out skull lesions create a distinctive radiological pattern. Can you identify the underlying haematological malignancy? Hint: Think of a plasma-cell disorder associated with osteolFacebook (Internacional) · 00:00 OutrasInternacional
Sunday, November 15
Rafat Abonour: My Top 10 Interventional Abstracts in Multiple Myeloma and AL Amyloidosis Ahead of ASH 2026Oncodaily · 20:49 InvestigaçãoRafat Abonour: My Top 10 Interventional Abstracts in Multiple Myeloma and AL Amyloidosis Ahead of ASH 2026 / ASH 2026, ASH26, cancer, multiple myeloma,
Al-Ola A. Abdallah: Four Emerging Research Highlights from ASH26Oncodaily · 18:52 InvestigaçãoAl-Ola A. Abdallah: Four Emerging Research Highlights from ASH26 / Al-Ola A Abdallah, ASH 2026, cancer care, Cancer research, Hematology, Myeloma, OncoDaily
Myeloma Paper of the Day, November 15th, Suggested by Robert OrlowskiOncodaily · 14:45 OutrasMyeloma Paper of the Day, November 15th, Suggested by Robert Orlowski / Angela Dispenzieri, Blood Cancer Journal, cancer, Daniel G. Packard, David Dingli,
Friday, November 13
CAR-NK Therapy for Multiple Myeloma: A Clinical Trial Success StoryHealth US News · 20:41 Doentes e associaçõesDiscover how an innovative CAR-NK cell therapy clinical trial led to complete remission for a patient facing relapsed multiple myeloma.
Six jobs for AI in myeloma care, from Prerna Mewawalla, M.D.Managed Healthcare Executive · 19:24 TratamentosOnly 19% of community oncologists use AI predictive models. Prerna Mewawalla, M.D., outlines six ways AI can already help in myeloma care.
Warburg Trap Therapy Selectively Triggers Apoptosis in Multiple Myeloma Cells in VitroBioengineer.org · 14:25 TratamentosA laboratory study demonstrates that combining mitochondrial complex I inhibitors with proton ionophores selectively triggers apoptosis and disrupts energy balance in multiple myeloma cells in vitro.
Wednesday, 11/11
- Tempest Therapeutics Exercises Option to License Senlang’s CD7-Targeted Lentiviral In Vivo CAR-T Platform Following Initial Phase 1 Results with Lead BCMA/GPRC5D CandidateGlobeNewswire (Internacional) · 13:53 TratamentosInternacional
-Tempest secures exclusive global rights outside China to a targeted lentiviral platform and portfolio of in vivo CAR-T candidates -Lead BCMA/GPRC5D...
ALDH2 Suppresses Multiple Myeloma Progression by Restraining the E2F Signaling PathwayBioengineer.org · 08:30 Outras
Legend Biotech shares tumble as Carvykti outlook overshadows profitBamboo Works · 04:23 Tratamentos
Monday, November 9th
European Commission Expands Melphalan Flufenamide Approval to Third-Line Treatment for Multiple MyelomaOncodaily · 12:52 Acesso e saúde públicaEuropean Commission Expands Melphalan Flufenamide Approval to Third-Line Treatment for Multiple Myeloma / dexamethasone, Drug Approval, EMA, European
Friday, November 6th
New European real-world evidence supporting Pepaxti in heavily pretreated multiple myeloma to be presented at ASH 2026News-Medical (Internacional) · 08:00 InvestigaçãoInternacionalOncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces that two abstracts highlighting real-world clinical outcomes for Pepaxti (melflufen) in relapsed, refractory multiple myeloma (RRMM) have been accepted for presentation at the 68th American Society…
Wednesday, 11/04
Modern rises 8% on early multiple myeloma data for its three-in-one mRNA therapy.TIKR.com · 08:00 TreatmentsPTSmall trial, big idea.
Tuesday, November 3rd
Targeted scan detects hidden multiple myeloma missed by standard imagingMedical Xpress (Internacional) · 15:00 OutrasInternacional
Advanced imaging tool improves detection of residual multiple myeloma diseaseNews-Medical (Internacional) · 08:00 TratamentosInternacionalA targeted immunoPET scan detected active multiple myeloma that standard PET/CT scans and blood tests missed, a finding that could help doctors more accurately map disease, guide treatment decisions and confirm whether cancer remains after therapy.
Standing in the Gaap: Raising multiple myeloma awareness through artBristol Myers Squibb (Internacional) · 08:00 Doentes e associaçõesInternacionalMultiple myeloma survivors and caregivers helped shape a Brooklyn mural designed to bring their experiences, community connections and stories into public view.
Friday, October 30th
Multiple myeloma and plasma cell disordersNature · 22:46 InvestigaçãoThis Collection invites research in the field of multiple myeloma and plasma cell disorders.
Annecy. Multiple myeloma: “This cancer is treatable but not curable.Le Dauphiné Libéré · 15:53 Patients and associationsFROn November 14th, the French Association of Multiple Myeloma Patients organizes in Annecy its 21st information day dedicated to this cancer of the...
Thursday, October 29th
Starton Therapeutics Signs Clinical Trial Agreement with the Stanford School of Medicine to Evaluate STAR-LLD in Combination with Novel CAR-T Therapy for Multiple MyelomaBusiness Wire (Internacional) · 07:00 TratamentosInternacional
